Filtros de búsqueda

Lista de obras de

A novel role of the corticotropin-releasing hormone (CRH) regulating peptide, teneurin-1 C-terminal associated peptide (TCAP-1), on glucose uptake into the brain.

artículo científico publicado en 2018

Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.

artículo científico publicado en 2017

Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities

scientific article published on 15 February 2019

Improved survival with vemurafenib in melanoma with BRAF V600E mutation

artículo científico publicado en 2011

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

artículo científico publicado en 2016

Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2

artículo científico publicado en 2019

Prognostic factors for first-line therapy and overall survival of metastatic uveal melanoma

artículo científico publicado en 2018

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma.

artículo científico publicado en 2015

Safety and efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

artículo científico publicado en 2014

The full blood count as a biomarker of outcome and toxicity in ipilimumab-treated cutaneous metastatic melanoma

artículo científico publicado en 2016

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda